These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Vascular endothelial growth factor A (VEGF-A) is involved in guidance of VEGF receptor-positive cells to the anterior portion of early embryos. Hiratsuka S; Kataoka Y; Nakao K; Nakamura K; Morikawa S; Tanaka S; Katsuki M; Maru Y; Shibuya M Mol Cell Biol; 2005 Jan; 25(1):355-63. PubMed ID: 15601856 [TBL] [Abstract][Full Text] [Related]
43. The Inorganic Perspective of VEGF: Interactions of Cu(2+) with Peptides Encompassing a Recognition Domain of the VEGF Receptor. Grasso G; Santoro AM; Magrì A; La Mendola D; Tomasello MF; Zimbone S; Rizzarelli E J Inorg Biochem; 2016 Jun; 159():149-58. PubMed ID: 27015654 [TBL] [Abstract][Full Text] [Related]
44. Localization of vascular endothelial growth factor and its receptors in digestive endocrine tumors: correlation with microvessel density and clinicopathologic features. La Rosa S; Uccella S; Finzi G; Albarello L; Sessa F; Capella C Hum Pathol; 2003 Jan; 34(1):18-27. PubMed ID: 12605362 [TBL] [Abstract][Full Text] [Related]
45. Intracrine VEGF signalling mediates colorectal cancer cell migration and invasion. Bhattacharya R; Fan F; Wang R; Ye X; Xia L; Boulbes D; Ellis LM Br J Cancer; 2017 Sep; 117(6):848-855. PubMed ID: 28742793 [TBL] [Abstract][Full Text] [Related]
46. Discovery of novel inhibitors of vascular endothelial growth factor-A-Neuropilin-1 interaction by structure-based virtual screening. Starzec A; Miteva MA; Ladam P; Villoutreix BO; Perret GY Bioorg Med Chem; 2014 Aug; 22(15):4042-8. PubMed ID: 24961874 [TBL] [Abstract][Full Text] [Related]
47. Peptides encoded by exon 6 of VEGF inhibit endothelial cell biological responses and angiogenesis induced by VEGF. Jia H; Jezequel S; Löhr M; Shaikh S; Davis D; Soker S; Selwood D; Zachary I Biochem Biophys Res Commun; 2001 Apr; 283(1):164-73. PubMed ID: 11322784 [TBL] [Abstract][Full Text] [Related]
48. Crystal structure of human vascular endothelial growth factor-B: identification of amino acids important for receptor binding. Iyer S; Scotney PD; Nash AD; Ravi Acharya K J Mol Biol; 2006 May; 359(1):76-85. PubMed ID: 16616187 [TBL] [Abstract][Full Text] [Related]
49. β-hairpin peptide that targets vascular endothelial growth factor (VEGF) receptors: design, NMR characterization, and biological activity. Diana D; Basile A; De Rosa L; Di Stasi R; Auriemma S; Arra C; Pedone C; Turco MC; Fattorusso R; D'Andrea LD J Biol Chem; 2011 Dec; 286(48):41680-41691. PubMed ID: 21969375 [TBL] [Abstract][Full Text] [Related]
50. Peptide Lv augments L-type voltage-gated calcium channels through vascular endothelial growth factor receptor 2 (VEGFR2) signaling. Shi L; Ko S; Ko ML; Kim AJ; Ko GY Biochim Biophys Acta; 2015 May; 1853(5):1154-64. PubMed ID: 25698653 [TBL] [Abstract][Full Text] [Related]
51. Expression of vascular endothelial growth factor (VEGF) and its receptors VEGFR1 and VEGFR2 in primary and recurrent WHO grade III meningiomas. Baumgarten P; Brokinkel B; Zinke J; Zachskorn C; Ebel H; Albert FK; Stummer W; Plate KH; Harter PN; Hasselblatt M; Mittelbronn M Histol Histopathol; 2013 Sep; 28(9):1157-66. PubMed ID: 23475388 [TBL] [Abstract][Full Text] [Related]
52. VEGFR1(D2) in drug discovery: Expression and molecular characterization. Di Stasi R; Diana D; Capasso D; Palumbo R; Romanelli A; Pedone C; Fattorusso R; D'Andrea LD Biopolymers; 2010; 94(6):800-9. PubMed ID: 20564033 [TBL] [Abstract][Full Text] [Related]
53. Serum and tissue profile of VEGF and its receptors VGFR1/R2 in children with infantile hemangiomas on systemic propranolol treatment. Przewratil P; Kobos J; Wnęk A; Szemraj J; Wyrzykowski D; Chrzanowska B; Andrzejewska E; Taran K Immunol Lett; 2016 Jul; 175():44-9. PubMed ID: 27178307 [TBL] [Abstract][Full Text] [Related]
54. Conformationally Constrained Peptides with High Affinity to the Vascular Endothelial Growth Factor. Guryanov I; Korzhikov-Vlakh V; Bhattacharya M; Biondi B; Masiero G; Formaggio F; Tennikova T; Urtti A J Med Chem; 2021 Aug; 64(15):10900-10907. PubMed ID: 34269584 [TBL] [Abstract][Full Text] [Related]
55. GDNF increases cell motility in human colon cancer through VEGF-VEGFR1 interaction. Huang SM; Chen TS; Chiu CM; Chang LK; Liao KF; Tan HM; Yeh WL; Chang GR; Wang MY; Lu DY Endocr Relat Cancer; 2014 Feb; 21(1):73-84. PubMed ID: 24165321 [TBL] [Abstract][Full Text] [Related]
56. Combined Use of Oligopeptides, Fragment Libraries, and Natural Compounds: A Comprehensive Approach To Sample the Druggability of Vascular Endothelial Growth Factor. Bayó-Puxan N; Rodríguez-Mias R; Goldflam M; Kotev M; Ciudad S; Hipolito CJ; Varese M; Suga H; Campos-Olivas R; Barril X; Guallar V; Teixidó M; García J; Giralt E ChemMedChem; 2016 Apr; 11(8):928-39. PubMed ID: 26553526 [TBL] [Abstract][Full Text] [Related]
59. Vascular endothelial growth factor acts in an autocrine manner in rhabdomyosarcoma cell lines and can be inhibited with all-trans-retinoic acid. Gee MF; Tsuchida R; Eichler-Jonsson C; Das B; Baruchel S; Malkin D Oncogene; 2005 Dec; 24(54):8025-37. PubMed ID: 16116481 [TBL] [Abstract][Full Text] [Related]
60. Discovery of pan-VEGF inhibitory peptides directed to the extracellular ligand-binding domains of the VEGF receptors. Michaloski JS; Redondo AR; Magalhães LS; Cambui CC; Giordano RJ Sci Adv; 2016 Oct; 2(10):e1600611. PubMed ID: 27819042 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]